MAIT cells are activated during human viral infections
Bonnie van Wilgenburg(The University of Melbourne), Paul Klenerman(John Radcliffe Hospital), Fiona M. Thompson(University of Oxford), Anita Y. M. Howe(St. Paul's Hospital), John Dillon(Mayo Clinic), Prida Malasit(Siriraj Hospital), Salim I. Khakoo(University Hospital Southampton NHS Foundation Trust), Maria Teresa Giordani(Ospedale San Bortolo), Paul Targett‐Adams(Medivir (Sweden)), Ayako Kurioka(University of Oxford), Sirijitt Vasanawathana(Khon Kaen University), Eleanor Barnes(Oxford Health NHS Foundation Trust), Lynn B. Dustin(Nuffield Orthopaedic Centre), Nicole Zitzmann(University of Oxford), Peter Vickerman(At Bristol), Christopher Holmes(University of Oxford), Jane A. McKeating(University of Oxford), Peter Shaw(Wenzhou Medical University), Tamyo Mbisa(Public Health England), Stephen M. Laidlaw(Nuffield Orthopaedic Centre), Diana Koletzki(Janssen (Belgium)), Paolo Fabris(Ospedale San Bortolo), Laura Denney(University of Oxford), Michael Moore(Indiana University School of Medicine), Iris Scherwitzl(Hammersmith Hospital), Duncan Young(University of Oxford), John McLauchlan(MRC University of Glasgow Centre for Virus Research), Graham R. Foster(Queen Mary University of London), Corinna A. Kulicke(University of Oxford), Peter Simmonds(University of Turku), Wannee Limpitikul(Songkhla Rajabhat University), Rachel Halford(The Hepatitis C Trust), Chris C. A. Spencer(Centre for Human Genetics), William L. Irving(University of Nottingham), Jonathan K. Ball(University of Nottingham), Ling‐Pei Ho(University of Oxford), Alec Miners(London School of Hygiene & Tropical Medicine), Edward Hutchinson(MRC University of Glasgow Centre for Virus Research), Emma Hudson(University of Oxford), Catherine de Lara(University of Oxford), Charles Gore(Medicines Patent Pool), Cham Herath(Gilead Sciences (United Kingdom)), Andrea Murray(Nottingham City Hospital), G Cooke(Imperial College London), Tianqi Leng(University of Oxford), Suzanne Cole(University of Oxford), Emma C. Thomson(MRC University of Glasgow Centre for Virus Research), Gary Burgess(Conatus Pharmaceuticals (United States)), Natasha K. Martin(University of California San Diego), Ye Htun Oo(University Hospitals Birmingham NHS Foundation Trust)
Cited by 520
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k